Engine Capital Management, LP Cyma Bay Therapeutics, Inc. Transaction History

Engine Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 17, 2020	SELL	$3.32 - $7.24 $5.86 Million - $12.8 Million	-1,766,196 Closed	0 $0
Q2 2020 Aug 18, 2020	BUY	$1.41 - $4.25 $2.38 Million - $7.17 Million	1,687,564 Added 2146.15%	1,766,196 $6.16 Million
Q2 2020 Aug 14, 2020	SELL	$1.41 - $4.25 $8.69 Million - $26.2 Million	-6,161,734 Reduced 98.74%	78,632 $543,000
Q1 2020 May 18, 2020	BUY	$1.25 - $2.02 $1.57 Million - $2.54 Million	1,256,432 Added 25.21%	6,240,366 $11.1 Million
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $6.63 Million - $29.6 Million	4,983,934 New	4,983,934 $9.77 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Engine Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Engine Capital Management, LP with notifications on news.